Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2024Egyptian Journal of Medical Human GeneticsOpen Access

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMagda Sayed MahmoudNational Research CentreMKMohamed K. KhalifaMisr University for Science and TechnologyANAmira M. NageebResearch Institute of Ophthalmology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mahmoud et al. (2024) studied this question.

synapsesocial.com/papers/68e71edfb6db643587698affhttps://doi.org/10.1186/s43042-024-00516-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MGMT promoter methylation in prognosis of patients with newly diagnosed IDH1 wildtype Glioblastoma2024
  2. 2IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation status2025 · 1 citations
  3. 3The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastoma2025 · 4 citations
  4. 4MOLECULAR MARKERS IN PREDICTING THE OUTCOME OF DIFFUSE GLIOMA GRADE 4 TREATMENT2025
  5. 55P IDH1 mutation status and overall survival in glioblastoma patients: A meta-analysis2024